ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection.

Engler, Melanie; Albers, Dan; Von Maltitz, Pascal; Groß, Rüdiger; Münch, Jan; Cirstea, Ion Cristian

Engler, Melanie; Albers, Dan; Von Maltitz, Pascal; Groß, Rüdiger; Münch, Jan; Cirstea, Ion Cristian.

Afiliación

Engler M; Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany.
Albers D; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Von Maltitz P; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Groß R; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Münch J; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Cirstea IC; Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany ion.cirstea@uni-ulm.de.

Life Sci Alliance ; 6(9)2023 09.

Article en En | MEDLINE | ID: mdl-37402592

Asunto(s)

COVID-19; Humanos; SARS-CoV-2/metabolismo; Enzima Convertidora de Angiotensina 2/metabolismo; Peptidil-Dipeptidasa A/metabolismo; Receptores ErbB/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Life Sci Alliance Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google